ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,164,000 | -35.7% | 300,000 | -37.2% | 0.06% | -76.7% |
| Q1 2019 | $1,811,000 | +1934.8% | 477,800 | +1185.4% | 0.26% | +1327.8% |
| Q4 2018 | $89,000 | -97.5% | 37,170 | -93.5% | 0.02% | -97.6% |
| Q3 2018 | $3,548,000 | +142.0% | 571,317 | +75.8% | 0.75% | +26.9% |
| Q2 2018 | $1,466,000 | +575.6% | 325,000 | +790.4% | 0.59% | +539.1% |
| Q2 2016 | $217,000 | – | 36,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |